SPDR S&P Biotech (XBI) 64.76 $XBI
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 64.76 (+1.11), JUNO: 48.64 (+0.84)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 64.76 (+1.11), JUNO: 48.64 (+0.84)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 201.33 (+0.12), VXX: 21.27 (-0.01), GLD: 110.87 (+1.73), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25), IAU: 11.18 (+0.17)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 136.36 (+2.73), ANTM: 140.49 (+3.16), HCA: 77.91 (+1.25), XBI: 64.76 (+1.11), UNH: 119.27 (+3.19), IBB: 308.45 (+1.25), XLV: 68.44 (+0.31)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 269.16 (-10.72), VRTX: 110.00 (+0.97), XBI: 64.76 (+1.11), INCY: 105.00 (+1.56)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 64.76 (+1.11)
Biotech ETFs Looking Attractive After Sell-Off
Sweta Killa - Zacks Investment Research - Thu Oct 01, 7:55AM CDT
The current slide in biotech sector made the stocks valuation attractive at the current levels.
BBP: 29.01 (+0.66), SBIO: 29.04 (+0.62), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25)
Top ETF Stories of September
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:34PM CDT
Inside the top financial stories of September and their impact on the world of ETFs.
71.02 (+0.31), KRE: 41.98 (-0.52), BBC: 27.46 (+0.43), SBIO: 29.04 (+0.62), VRX: 175.94 (+4.77), EWG: 26.26 (+0.22), IAI: 38.86 (-0.39), REM: 10.38 (-0.02), XBI: 64.76 (+1.11), EDV: 117.10 (+0.21), IBB: 308.45 (+1.25), GDX: 16.26 (+0.85)
Notable ETF Inflow Detected - XBI, ZIOP, ACHN, ZFGN
ETFChannel.com - Wed Sep 30, 9:52AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $186.0 million dollar inflow -- that's a 10.1% increase...
XBI: 64.76 (+1.11)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 7.19% Sell Off
Comtex SmarTrend(R) - Mon Sep 28, 4:09PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.28 to a high of $67.06. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $65.98 on volume of 14.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 64.76 (+1.11)
Drug Pricing Fears Erase Biotech Stock Gains for the Year
at The Street - Mon Sep 28, 12:33PM CDT
The bloodletting in biotech stocks continued Monday with aggressive selling erasing the year's gains in a key sector exchange-traded fund. Another closely-followed ETF is barely hanging on to its outperformance.
BIIB: 269.16 (-10.72), VRX: 175.94 (+4.77), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25)
Ill at Ease with Biotech? Prescribing #1 Healthcare ETFs
Zacks Equity Research - Zacks Investment Research - Mon Sep 28, 11:16AM CDT
Since the hot biotech ETF space appears to be on a correction mode, investors can invest in these better-insulated healthcare ETFs.
XHE: 43.92 (+0.14), SBIO: 29.04 (+0.62), BBC: 27.46 (+0.43), PSCH: 65.69 (+0.61), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25), IHI: 115.18 (+0.90)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 1.23% Yesterday
Comtex SmarTrend(R) - Thu Sep 24, 4:42PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $70.15 to a high of $72.98. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $72.05 on volume of 4.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 64.76 (+1.11)
The 3 Key Factors in Biotech ETF Investing
Eric Dutram - Zacks Investment Research - Thu Sep 24, 1:57PM CDT
What do investors need to know about the biotech ETF investing space?
FBT: 102.26 (+1.35), UBIO: 9.23 (+0.11), XBI: 64.76 (+1.11), BBH: 116.42 (+0.29), IBB: 308.45 (+1.25), LABU: 18.01 (+0.92)
Materials Stocks Lead Markets Sharply Lower as China Takes Focus
at The Street - Tue Sep 22, 2:03PM CDT
Stocks extend sharp losses by midday Tuesday as renewed fears over the health of China's economy send commodity markets tumbling.
XLB: 44.15 (-0.02), CCL: 49.36 (-0.26), CAG: 41.76 (-0.01), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25), BAC: 15.58 (-0.17), DRI: 66.68 (-0.08), LYB: 95.45 (-2.05), GS: 179.19 (-1.88), AZO: 736.92 (+1.61), BHP: 37.76 (+0.44), RIO: 39.74 (+0.93), DOW: 47.08 (-0.71), AAPL: 112.12 (+2.62), GIS: 56.61 (+0.13)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 64.76 (+1.11), JUNO: 48.64 (+0.84)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 64.76 (+1.11), JUNO: 48.64 (+0.84)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 201.33 (+0.12), VXX: 21.27 (-0.01), GLD: 110.87 (+1.73), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25), IAU: 11.18 (+0.17)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 136.36 (+2.73), ANTM: 140.49 (+3.16), HCA: 77.91 (+1.25), XBI: 64.76 (+1.11), UNH: 119.27 (+3.19), IBB: 308.45 (+1.25), XLV: 68.44 (+0.31)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 269.16 (-10.72), VRTX: 110.00 (+0.97), XBI: 64.76 (+1.11), INCY: 105.00 (+1.56)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 64.76 (+1.11)
Biotech ETFs Looking Attractive After Sell-Off
Sweta Killa - Zacks Investment Research - Thu Oct 01, 7:55AM CDT
The current slide in biotech sector made the stocks valuation attractive at the current levels.
BBP: 29.01 (+0.66), SBIO: 29.04 (+0.62), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25)
Top ETF Stories of September
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:34PM CDT
Inside the top financial stories of September and their impact on the world of ETFs.
71.02 (+0.31), KRE: 41.98 (-0.52), BBC: 27.46 (+0.43), SBIO: 29.04 (+0.62), VRX: 175.94 (+4.77), EWG: 26.26 (+0.22), IAI: 38.86 (-0.39), REM: 10.38 (-0.02), XBI: 64.76 (+1.11), EDV: 117.10 (+0.21), IBB: 308.45 (+1.25), GDX: 16.26 (+0.85) Notable ETF Inflow Detected - XBI, ZIOP, ACHN, ZFGN
ETFChannel.com - Wed Sep 30, 9:52AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $186.0 million dollar inflow -- that's a 10.1% increase...
XBI: 64.76 (+1.11)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 7.19% Sell Off
Comtex SmarTrend(R) - Mon Sep 28, 4:09PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.28 to a high of $67.06. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $65.98 on volume of 14.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 64.76 (+1.11)
Drug Pricing Fears Erase Biotech Stock Gains for the Year
at The Street - Mon Sep 28, 12:33PM CDT
The bloodletting in biotech stocks continued Monday with aggressive selling erasing the year's gains in a key sector exchange-traded fund. Another closely-followed ETF is barely hanging on to its outperformance.
BIIB: 269.16 (-10.72), VRX: 175.94 (+4.77), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25)
Ill at Ease with Biotech? Prescribing #1 Healthcare ETFs
Zacks Equity Research - Zacks Investment Research - Mon Sep 28, 11:16AM CDT
Since the hot biotech ETF space appears to be on a correction mode, investors can invest in these better-insulated healthcare ETFs.
XHE: 43.92 (+0.14), SBIO: 29.04 (+0.62), BBC: 27.46 (+0.43), PSCH: 65.69 (+0.61), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25), IHI: 115.18 (+0.90)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 1.23% Yesterday
Comtex SmarTrend(R) - Thu Sep 24, 4:42PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $70.15 to a high of $72.98. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $72.05 on volume of 4.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 64.76 (+1.11)
The 3 Key Factors in Biotech ETF Investing
Eric Dutram - Zacks Investment Research - Thu Sep 24, 1:57PM CDT
What do investors need to know about the biotech ETF investing space?
FBT: 102.26 (+1.35), UBIO: 9.23 (+0.11), XBI: 64.76 (+1.11), BBH: 116.42 (+0.29), IBB: 308.45 (+1.25), LABU: 18.01 (+0.92)
Materials Stocks Lead Markets Sharply Lower as China Takes Focus
at The Street - Tue Sep 22, 2:03PM CDT
Stocks extend sharp losses by midday Tuesday as renewed fears over the health of China's economy send commodity markets tumbling.
XLB: 44.15 (-0.02), CCL: 49.36 (-0.26), CAG: 41.76 (-0.01), XBI: 64.76 (+1.11), IBB: 308.45 (+1.25), BAC: 15.58 (-0.17), DRI: 66.68 (-0.08), LYB: 95.45 (-2.05), GS: 179.19 (-1.88), AZO: 736.92 (+1.61), BHP: 37.76 (+0.44), RIO: 39.74 (+0.93), DOW: 47.08 (-0.71), AAPL: 112.12 (+2.62), GIS: 56.61 (+0.13)
